FDA inspection
Niagara Pharmaceuticals Inc: FDA inspection ending Apr 25, 2022
FDA inspection 1167881 · Voluntary Action Indicated (VAI) · Dundas
Key facts
| Inspection ID | 1167881 |
|---|---|
| Firm | Niagara Pharmaceuticals Inc |
| FEI number | 3003093882 |
| Address | 60 Innovation Dr |
| City | Dundas |
| Country | Canada |
| Fiscal year | 2022 |
| Inspection end date | Apr 25, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data